# A Trial for Patients With Gestational Trophoblastic Disease

> **NCT00190918** · PHASE2 · COMPLETED · sponsor: **Eli Lilly and Company** · enrollment: 50 (estimated)

## Conditions studied

- Trophoblastic Neoplasms
- Uterine Neoplasms
- Hydatidiform Mole
- Choriocarcinoma

## Interventions

- **DRUG:** Pemetrexed

## Key facts

- **NCT ID:** NCT00190918
- **Lead sponsor:** Eli Lilly and Company
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-07
- **Primary completion:** —
- **Final completion:** 2007-07
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2007-08-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00190918

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00190918, "A Trial for Patients With Gestational Trophoblastic Disease". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT00190918. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*